Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma

被引：6

作者：

Aznar Martinez, Laura ^{[1
]}

Lopez Cubillana, Pedro ^{[1
]}

Lopez Abadb, Alicia ^{[2
]}

Vidal Crespo, Natalia ^{[1
]}

Gomez Gomez, Guillermo Antonio ^{[1
]}

机构：

[1] Virgen de la Arrixaca Clin Univ Hosp, Dept Urol, Enrique Gallego 17, ES-30120 Murcia, Spain

[2] Univ Murcia, Dept Urol, Murcia, Spain

来源：

UROLOGIA INTERNATIONALIS | 2019年 / 103卷 / 02期

关键词：

Nonmuscle invasive bladder cancer; Immunosuppressed; Kidney transplant; Treatment; RENAL-TRANSPLANT RECIPIENTS; TRANSITIONAL-CELL CARCINOMA; CANCER;

D O I：

10.1159/000501108

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Due to their immunosuppressed status, solid organ transplant recipients are a special group of patients with an incidence of bladder cancer greater than the rest of the population, especially in the first 6 years after transplantation. Also, treatment with Bacillus Calmette-Guerin, a reference therapy in nonmuscle invasive high-risk bladder cancer, may be less effective in this group of patients and could cause more adverse effects. However, the data published so far and the experience initiated in the Virgen de la Arrixaca Clinical University Hospital do not support these hypotheses. (C) 2019 S. Karger AG, Basel

引用

页码：242 / 244

页数：3

共 50 条

[1] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
Khanna, Abhinav
Yerram, Nitin
Zhu, Hui
Kim, Simon
Abouassaly, Robert
UROLOGY, 2019, 124 : 120 - 125
[2] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
Hugar, Lee A.
Gilbert, Scott M.
Sexton, Wade J.
Kamat, Ashish M.
Li, Roger
CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
[3] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages REPLY
Khanna, Abhinav
Abouassaly, Robert
UROLOGY, 2019, 124 : 126 - 126
[4] INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES
Azer, S.
Ranasinghe, W.
Webb, C.
Lioufas, P. A.
Cetti, R.
Frydenberg, M.
Bolton, D.
Appu, S.
Sengupta, S.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 40 - 40
[5] Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous Pembrolizumab in high grade nonmuscle invasive bladder cancer
Alanee, Shaheen
El Zawahry, Ahmed
Sana, Sherjeel
McVary, Kevin
Robinson, Kathy
Rao, Krishna A.
CANCER RESEARCH, 2019, 79 (13)
[6] PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN HIGH GRADE NONMUSCLE INVASIVE BLADDER CANCER
Alanee, Shaheen
El-Zawahry, Ahmed
McVary, Kevin
Deebajah, Mustafa
Sana, Sherjeel
Robinson, Kathy
Rao, Krishna
JOURNAL OF UROLOGY, 2019, 201 (04): : E620 - E621
[7] Emerging Immunotherapy Options for bacillus Calmette-Guerin Unresponsive Nonmuscle Invasive Bladder Cancer
Meng, Maxwell V.
Gschwend, Juergen E.
Shore, Neal
Grossfeld, Gary D.
Mostafid, Hugh
Black, Peter C.
JOURNAL OF UROLOGY, 2019, 202 (06): : 1111 - 1119
[8] Outcomes of Intravesical bacillus Calmette-Guerin in a Multiracial Cohort with Nonmuscle Invasive Bladder Cancer
Barry, Emily
Agalliu, Ilir
Maiman, Richard
Shreck, Evan
Kovac, Evan
Aboumohamed, Ahmed
Sankin, Alexander
UROLOGY PRACTICE, 2021, 8 (01) : 100 - 105
[9] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages EDITORIAL COMMENT
Bandari, Jathin
Maganty, Avinash
Davies, Benjamin J.
UROLOGY, 2019, 124 : 125 - 126
[10] Renal Tuberculosis Following Intravesical Bacillus Calmette-Guerin for High-grade Non-muscle-invasive Bladder Cancer
Sihra, Neha
Diasuke, Nonaka
Thurairaja, Ramesh
Khan, Muhammad Shamim
Malde, Sachin
UROLOGY, 2017, 107 : E3 - E4

← 1 2 3 4 5 →